Description:
Ritonavir IP 100 mg Capsule is an antiretroviral medication used in the treatment of HIV (Human Immunodeficiency Virus) infection. It belongs to the class of protease inhibitors (PIs) and works by inhibiting the HIV protease enzyme, which is essential for viral replication. By preventing the production of mature viral particles, Ritonavir helps reduce the viral load and supports immune system recovery.
Therapeutic Uses:
Treatment of HIV-1 infection in adults and children, in combination with other antiretroviral agents
Often used as a pharmacokinetic booster to enhance the effectiveness of other protease inhibitors by increasing their plasma concentrations
Mechanism of Action:
Ritonavir inhibits the HIV protease enzyme, preventing the cleavage of viral polyproteins into functional proteins, which are necessary for assembling infectious virus particles. This action stops the virus from multiplying further in the body.
Packaging:
Available in capsule form, typically supplied in blister strips or bottles. Common packaging includes 10x10 capsules (100 capsules per box) or as per regulatory and client specifications.
Note:
Ritonavir is not a cure for HIV/AIDS but significantly aids in controlling the infection when used as part of a combination antiretroviral regimen. It should be taken under the supervision of a healthcare professional, with regular monitoring of liver function and drug interactions.
Would you like a version formatted for marketing brochures or regulatory submission?
